The group found that SLC18A2 mRNA expression levels were significantly decreased in prostate cancer samples, with low expression levels significantly associated with PSA recurrence after radical prostatectomy (multivariate hazard ratio (HR) 0.13, p < 0.05) suggestive of independent prognostic value [56]. This evidence concerns the gene KLK3 and Familial prostate cancer.